Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stability.
- 1 January 1999
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (11), 1687-1693
- https://doi.org/10.1023/a:1018945713623
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics and Bioavailability of the Anti-Human Immunodeficiency Virus Nucleotide Analog 9-[( R )2-(Phosphonomethoxy)Propyl]Adenine (PMPA) in DogsAntimicrobial Agents and Chemotherapy, 1998
- Anti‐Human Immunodeficiency Virus (HIV) Activity, Safety, and Pharmacokinetics of Adefovir Dipivoxil (9‐[2‐(bis‐pivaloyloxymethyl)‐phosphonylmethoxyethyl]adenine) in HIV‐Infected PatientsThe Journal of Infectious Diseases, 1997
- Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.1997
- Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.1996
- Neighboring Group Catalysis in the Design of Nucleotide ProdrugsJournal of Medicinal Chemistry, 1996
- Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patientsAntimicrobial Agents and Chemotherapy, 1995
- 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivoAntimicrobial Agents and Chemotherapy, 1994
- Enantioselective and Reversible Inhibition of Trypsin and .alpha.-Chymotrypsin by Phosphonate EstersBiochemistry, 1994
- Enzymic hydrolysis of phosphonate esters. Reaction mechanism of intestinal 5'-nucleotide phosphodiesteraseBiochemistry, 1977
- Hydrolysis of phosphonate esters catalyzed by 5'-nucleotide phosphodiesteraseBiochemistry, 1975